Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

President Donald Trump’s pick to lead the US Patent and Trademark Office is setting off alarm bells for tech companies and ...

Fish & Richardson bumped gross revenue up to nearly $520 million in 2024. President and CEO John Adkisson attributed the gain ...

Rival law firms announced the hires of five partners from Weil, Gotshal & Manges on Monday, including two practice leaders, ...

The settlement agreement resolves the patent litigation brought by Axsome on Hikma for submitting an abbreviated new drug application to the FDA, seeking marketing approval for a generic version ...

On the 13th, the 24th division of the Patent Court (Director General WOOSUNG) partially accepted the claims of LS Cable & ...

President Donald Trump has nominated Dilworth Paxson partner John A. Squires to serve as the director of the US Patent and ...

This Article analyzes over 89,000 patents litigated over a twenty-year period to determine how the number of office actions ...

As required by law, Axsome and Hikma will submit the settlement agreement to the U.S. Federal Trade Commission and the U.S.

Jones Day sees the mix of genomics and life sciences, two specialties of the duo, working nicely with the firm’s existing client base in tech.

Eric J. Fues and Kyle W. Howarth of Finnegan discuss decisions exploring the multi-pronged analysis in patent law for ...